Exsilio Therapeutics

About:

Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

Website: https://exsiliotx.com

Top Investors: OrbiMed, Insight Partners, Invus, CRISPR Therapeutics, Novartis Venture Fund

Description:

Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells.